(Q43973104)

28 November 2017

title

Sexual inactivity results in reversible reduction of LH bioavailability (English)

1 reference

28 November 2017

1 reference

Carosa E

1

1 reference

28 November 2017

Benvenga S

2

1 reference

28 November 2017

Trimarchi F

3

1 reference

28 November 2017

Lenzi A

4

1 reference

28 November 2017

Pepe M

5

1 reference

28 November 2017

Simonelli C

6

1 reference

28 November 2017

Jannini EA

7

1 reference

28 November 2017

publication date

1 April 2002

1 reference

International Journal of Impotence Research

28 November 2017

published in

1 reference

28 November 2017

volume

14

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

93-9; discussion 100

1 reference

Is routine endocrine testing of impotent men necessary?

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Affective and physiological sexual response patterns: the effects of instructions on sexually functional and dysfunctional men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

InVitroBioassay of LH in Human Serum: The Rat Interstitial Cell Testosterone (RICT) Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Venous surgery in erectile dysfunction. The role of dorsal-penile-vein ligation and spongiosolysis for impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

The GnRH family of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Constancy of opioid control of luteinizing hormone in different pathophysiological states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

Effects of aging and illness on the pituitary testicular axis in men: qualitative as well as quantitative changes in luteinizing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

1 reference

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

1 reference

7 January 2021

Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

The negative pressure device for erectile disorders: when does it fail?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Erectile function and naltrexone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900832

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3900832

1 reference

Dimensions Publication ID

28 November 2017

1025265653

0 references

1 reference